PLATELET ALPHA-2-ADRENERGIC RECEPTOR-BINDING SITES IN MAJOR DEPRESSIVE DISORDER AND BORDERLINE PERSONALITY-DISORDER

被引:13
|
作者
SOUTHWICK, SM
YEHUDA, R
GILLER, EL
PERRY, BD
机构
[1] UNIV CHICAGO, DEPT PSYCHIAT,CHILD & ADOLESCENT PSYCHIAT SECT, BOX 411,5841 S MARYLAND AVE, CHICAGO, IL 60637 USA
[2] UNIV CONNECTICUT, CTR HLTH, UNIV HOSP PROGRAMS, FARMINGTON, CT 06032 USA
[3] VET ADM MED CTR, POSTRAUMAT STRESS DISORDER PROGRAM, W HAVEN, CT 06516 USA
[4] NATL CTR POSTRAUMAT STRESS DISORDER, DIV CLIN NEUROSCI, NEW HAVEN, CT USA
[5] YALE UNIV, SCH MED, PSYCHIAT, NEW HAVEN, CT 06510 USA
[6] UNIV CONNECTICUT, CTR HLTH, PSYCHIAT PSYCHOL, FARMINGTON, CT 06032 USA
[7] VET ADM MED CTR, PSYCHIAT SERV, W HAVEN, CT 06516 USA
[8] UNIV CONNECTICUT, CTR HLTH, PSYCHIAT, FARMINGTON, CT 06032 USA
关键词
!sup]3[!/sup]H-rauwolscine; borderline personality disorder; catecholamines; major depressive disorder; Platelet α[!sub]2[!/sub]-adrenergic receptor binding; radioligand binding studies;
D O I
10.1016/0165-1781(90)90019-2
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Platelet α2-adrenergic receptor binding sites were measured in a group of patients with major depressive disorder (MDD) (n = 23) and in normal controls (n = 25). When all depressed subjects were compared to controls, there were no differences in either Kd (affinity of the ligand) or total binding site (number/platelet), although a significant change in the ratio of high to low affinity states was observed in the depressed group. When the depressed patients were subdivided into those with and without a co-occuring borderline personality disorder (BPD), the BPD group had significantly fewer α2 high affinity binding sites, while the group with depression alone had significantly more binding sites (both low and high affinity) than the control group. The results support the concept that assessment of comorbid diagnoses may be essential to biological studies of depression. © 1990.
引用
收藏
页码:193 / 203
页数:11
相关论文
共 50 条
  • [31] Common and distinct structural network abnormalities in major depressive disorder and borderline personality disorder
    Depping, Malte S.
    Wolf, Nadine D.
    Vasic, Nenad
    Sambataro, Fabio
    Thomann, Philipp A.
    Wolf, R. Christian
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 65 : 127 - 133
  • [32] Effectiveness of Electroconvulsive Therapy in Patients With Major Depressive Disorder and Comorbid Borderline Personality Disorder
    Lee, James H.
    Kung, Simon
    Rasmussen, Keith G.
    Palmer, Brian A.
    JOURNAL OF ECT, 2019, 35 (01) : 44 - 47
  • [33] DOES BORDERLINE PERSONALITY DISORDER MANIFEST ITSELF DIFFERENTLY IN PATIENTS WITH BIPOLAR DISORDER AND MAJOR DEPRESSIVE DISORDER?
    Zimmerman, Mark
    Morgan, Theresa A.
    Young, Diane
    Chelminski, Iwona
    Dalrymple, Kristy
    Walsh, Emily
    JOURNAL OF PERSONALITY DISORDERS, 2015, 29 (06) : 847 - 853
  • [34] Differentiating the Everyday Emotion Dynamics of Borderline Personality Disorder From Major Depressive Disorder and Bipolar Disorder
    Mneimne, Malek
    Fleeson, William
    Arnold, Elizabeth Mayfield
    Furr, R. Michael
    PERSONALITY DISORDERS-THEORY RESEARCH AND TREATMENT, 2018, 9 (02) : 192 - 196
  • [35] Executive functions and borderline personality features in adolescents with major depressive disorder
    Albermann, Mona
    Emery, Sophie
    Baumgartner, Noemi
    Strumberger, Michael
    Erb, Suzanne
    Woeckel, Lars
    Mueller-Knapp, Ulrich
    Rhiner, Bruno
    Contin-Waldvogel, Brigitte
    Bachmann, Silke
    Schmeck, Klaus
    Berger, Gregor
    Haeberling, Isabelle
    FRONTIERS IN HUMAN NEUROSCIENCE, 2023, 17
  • [36] GLUCOCORTICOID RECEPTOR-BINDING IN 3 DIFFERENT CELL-TYPES IN MAJOR DEPRESSIVE DISORDER - LACK OF EVIDENCE OF RECEPTOR-BINDING DEFECT
    WASSEF, AA
    OBOYLE, M
    GARDNER, R
    ROSE, RM
    BROWN, A
    HARRIS, A
    NGUYEN, H
    MEYER, WJ
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1992, 16 (01): : 65 - 78
  • [37] PLATELET ALPHA-2-ADRENERGIC RECEPTOR-BINDING AND PLASMA-CATECHOLAMINES - BEFORE AND DURING IMIPRAMINE TREATMENT IN PATIENTS WITH PANIC ANXIETY
    CAMERON, OG
    SMITH, CB
    HOLLINGSWORTH, PJ
    NESSE, RM
    CURTIS, GC
    ARCHIVES OF GENERAL PSYCHIATRY, 1984, 41 (12) : 1144 - 1148
  • [38] Platelet glutamate receptor supersensitivity in major depressive disorder
    Berk, M
    Plein, H
    Ferreira, D
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (03) : 129 - 132
  • [39] Exploring the role of affective temperaments: predicting major depressive disorder in the context of borderline personality disorder
    Sair, Yasan Bilge
    Saracoglu, Irem
    POSTGRADUATE MEDICINE, 2024, 136 (07) : 764 - 769
  • [40] Clinical evaluation of Major Depressive Disorder (MDD) and Borderline Personality Disorder(BPD) in youth adolescents
    Kaleda, V.
    Krylova, E.
    Kuleshov, A.
    Beburishvili, A.
    EUROPEAN PSYCHIATRY, 2022, 65 : S328 - S328